Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 21, 2005; 11(39): 6104-6109
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6104
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6104
Table 1 Patients’ characteristics according to treatment
TACE | TACE-PEI | |
Patients (n) | 25 | 27 |
ean age yr (range) | 63.6 (48-79) | 64 (47-76) |
M:F (%) | 84:16 | 74.1:25.9 |
Cirrhosis/no cirrhosis | 22/3 | 23/4 |
Etiology of cirrhosis (n/%) | ||
Alcohol | 12 (55) | 13 (57) |
Hepatitis B or C | 7 (32) | 7 (30) |
Hemochromatosis | 2 (9) | 1 (4) |
Unknown | 1 (4) | 2 (9) |
Liver function (n/%) | ||
Child Pugh A | 22 (88) | 17 (63) |
Child Pugh B | 3 (12) | 10 (37) |
Child Pugh C | 0 | 0 |
Tumor stage (n) | ||
Okuda I | 19 | 17 |
Okuda II | 6 | 9 |
Okuda III | 0 | 1 |
AFP | ||
<100 ng/mL | 14 | 15 |
≥100 ng/mL | 11 | 12 |
Portal vein thrombosis (partial or complete) | 8 | 6 |
Number of tumor lesions | ||
1 | 9 | 13 |
2 | 6 | 5 |
3 | 5 | 2 |
>3 | 4 | 5 |
Diffuse | 0 | 2 |
Not documented | 1 | 0 |
Largest diameter >5 cm (US) | 17 | 17 |
- Citation: Becker G, Soezgen T, Olschewski M, Laubenberger J, Blum HE, Allgaier HP. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005; 11(39): 6104-6109
- URL: https://www.wjgnet.com/1007-9327/full/v11/i39/6104.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i39.6104